Can a smartphone app help breast cancer patients stay on track with Life-Saving pills?
NCT ID NCT05488145
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a web-based app could help women with early-stage hormone-positive breast cancer take their daily hormone therapy more consistently. Many patients stop taking these pills due to side effects or lack of support, which raises the risk of cancer returning. The app provided reminders, educational videos, and direct contact with nurses to help patients stay on track. The study enrolled 21 participants and focused on whether patients found the app easy to use and whether it improved their medication adherence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE I BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory Johns Creek Hospital
Johns Creek, Georgia, 30097, United States
-
Emory Saint Joseph's Hospital
Atlanta, Georgia, 30342, United States
-
Emory University Hospital Midtown
Atlanta, Georgia, 30308, United States
-
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fasting during chemo: a new way to boost treatment?
- Gut bacteria may fortify bones in breast cancer therapy
- Can a smart drug cross the Blood-Brain barrier to attack breast cancer metastases?
- Digital therapy aims to tame the fear that haunts cancer survivors
- Gentle tai chi may soothe joint pain caused by breast cancer treatment
- A remote diet and exercise program aims to help rural cancer survivors shed pounds and lower recurrence risk